Hämoglobinlabor Universitätsklinikum Ulm, Klinik für Kinder und Jugendmedizin, Eythstr. 24, 89075 Ulm, Germany.
Dtsch Arztebl Int. 2010 Feb;107(5):65-71. doi: 10.3238/arztebl.2010.0065. Epub 2010 Feb 5.
Hemoglobinopathies are among the most common hereditary diseases worldwide, with high prevalence in the Mediterranean basin, Africa, and Asia. Although they are rare in the indigenous central European population, they have become much more common in Germany recently through the immigration of millions of people from endemic regions.
In a long-term study (1971-2007), 100,621 hemoglobin analyses were performed and retrospectively evaluated. Basic clinical and hematological information were provided by the participating physicians. The hemoglobin defects were characterized with hematological and biochemical methods, as well as by DNA analysis in selected cases (from the mid-1980's onward). 73% of the analyses were performed in patients with an immigration background, 27% in patients of German ethnic origin.
34,228 persons, or 34% of those studied, were found to have a hemoglobinopathy. Most cases involved thalassemia syndromes (25,798 cases, 25.6%); the second most common type was a structural abnormality of hemoglobin (8,430 cases, 8.4%). This study provides the first broad overview of the occurrence, spectrum, and geographical distribution of hemoglobinopathies in Germany.
These data show that hemoglobinopathies are a relevant health problem in the population of Germany today. This is not an epidemiological study, and thus it is unknown to what extent these data are representative. Because hemoglobin defects are of widely diverse genetic and clinical types, specialized laboratory analysis is needed to diagnose them correctly and provide a basis for proper therapeutic decisions.
血红蛋白病是全球最常见的遗传性疾病之一,在地中海盆地、非洲和亚洲的发病率很高。尽管它们在中欧本地人群中很少见,但近年来,由于来自流行地区的数百万人移民,德国的发病率已经大大增加。
在一项长期研究(1971-2007 年)中,进行了 100621 次血红蛋白分析,并进行了回顾性评估。参与的医生提供了基本的临床和血液学信息。血红蛋白缺陷通过血液学和生化方法以及在选定病例中进行 DNA 分析(从 20 世纪 80 年代中期开始)进行特征描述。73%的分析是在有移民背景的患者中进行的,27%的分析是在德国血统的患者中进行的。
34228 人,即研究对象的 34%,被发现患有血红蛋白病。大多数病例涉及地中海贫血综合征(25798 例,25.6%);第二种最常见的类型是血红蛋白结构异常(8430 例,8.4%)。本研究首次全面概述了德国血红蛋白病的发生、谱和地理分布。
这些数据表明,血红蛋白病是当今德国人口中的一个重要健康问题。这不是一项流行病学研究,因此,目前尚不清楚这些数据在多大程度上具有代表性。由于血红蛋白缺陷具有广泛多样的遗传和临床类型,因此需要专门的实验室分析来正确诊断并为适当的治疗决策提供依据。